European Medicines Agency (EMA) has published a guide to help gene and cell therapy developers navigate the most important regulatory requirements during the non-clinical development phase.
Non-clinical Development Flowchart
Follow the link to non-clinical development flowchart and checklist:
Czy uważasz informacje na tej stronie za pomocne? Przyślij nam swoje uwagi